Qmsmedicalallied earnings calls.
Other · 1 quarter tracked · source-linked performance, management guidance and promise context.
Latest revenue
₹172.9 Cr
financial record pending verification
Quarters tracked
1
source records in the directory
Delivery assessment
Unscored
No scored management commitments are present yet.
Call date
Pending
latest available source date
Signal trajectory
1 actual quarterCurrent read
Unscored
No scored management commitments are present yet.
Latest source read
What changed this quarter?
QMS Medical Allied Services delivered 11% revenue growth to 172.9 crore in FY26, with EBITDA at 25.9 crore and PAT at 11.9 crore. While the top line growth was solid, EBITDA margins compressed to ~15% versus management's guided 17%, due to frontloaded investments in the services segment—specifically hiring ~1,200 employees for new patient service program contracts. The product segment faced supply chain disruptions in H2, causing revenue moderation. Management targets doubling service revenue to ~100 crore in FY27, driven by new GLP-1 related patient support programs and camp expansion. Camp revenue is guided at 18-20 crore. However, sustainability of the margin recovery remains uncertain as the company continues building infrastructure for new contracts. The main risk is margin pressure from pre-revenue investments and product segment supply headwinds, partially offset by strong visibility from locked-in service contracts.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Watch
Revenue
₹172.9 Cr
Source date
Pending
Across the record
Quarter history.
History modules